547 related articles for article (PubMed ID: 23088810)
41. Alterations in mRNA and protein levels of metalloproteinases-2, -9, and -14 and tissue inhibitor of metalloproteinase-2 responses to traumatic skeletal muscle injury.
Barnes BR; Szelenyi ER; Warren GL; Urso ML
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1501-8. PubMed ID: 19794148
[TBL] [Abstract][Full Text] [Related]
42. Low testosterone elevates interleukin family cytokines in a rodent model: a possible mechanism for the potentiation of vascular disease in androgen-deficient males.
Freeman BM; Mountain DJ; Brock TC; Chapman JR; Kirkpatrick SS; Freeman MB; Klein FA; Grandas OH
J Surg Res; 2014 Jul; 190(1):319-27. PubMed ID: 24703604
[TBL] [Abstract][Full Text] [Related]
43. Coordinated elevation of membrane type 1-matrix metalloproteinase and matrix metalloproteinase-2 expression in rat uterus during postpartum involution.
Manase K; Endo T; Chida M; Nagasawa K; Honnma H; Yamazaki K; Kitajima Y; Goto T; Kanaya M; Hayashi T; Mitaka T; Saito T
Reprod Biol Endocrinol; 2006 Jun; 4():32. PubMed ID: 16740171
[TBL] [Abstract][Full Text] [Related]
44. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
45. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
[TBL] [Abstract][Full Text] [Related]
46. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
Tsukioka K; Suzuki J; Kawauchi M; Wada Y; Zhang T; Nishio A; Koide N; Endoh M; Takayama K; Takamoto S; Isobe M; Amano J
J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
[TBL] [Abstract][Full Text] [Related]
47. Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery.
Orozco-Sevilla V; Naftalovich R; Hoffmann T; London D; Czernizer E; Yang C; Dardik A; Dardik H
J Vasc Surg; 2013 Nov; 58(5):1360-5. PubMed ID: 23538007
[TBL] [Abstract][Full Text] [Related]
48. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
49. Effect of estrogen therapy on vascular perlecan and metalloproteinases 2 and 9 in castrated rats.
Pompei LM; Steiner ML; Theodoro TR; Souza PZ; Romanini AC; Coulson-Thomas V; Pinhal MA; Fernandes CE
Climacteric; 2013 Feb; 16(1):147-53. PubMed ID: 22640525
[TBL] [Abstract][Full Text] [Related]
50. Potent inhibition of arterial intimal hyperplasia by TIMP1 gene transfer using AAV vectors.
Ramirez Correa GA; Zacchigna S; Arsic N; Zentilin L; Salvi A; Sinagra G; Giacca M
Mol Ther; 2004 Jun; 9(6):876-84. PubMed ID: 15194054
[TBL] [Abstract][Full Text] [Related]
51. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway.
Hollenbeck ST; Sakakibara K; Faries PL; Workhu B; Liu B; Kent KC
J Surg Res; 2004 Aug; 120(2):288-94. PubMed ID: 15234225
[TBL] [Abstract][Full Text] [Related]
52. p53 gene therapy modulates signal transduction in the apoptotic and cell cycle pathways downregulating neointimal hyperplasia.
Jacob T; Hingorani A; Ascher E
Vasc Endovascular Surg; 2012 Jan; 46(1):45-53. PubMed ID: 22156152
[TBL] [Abstract][Full Text] [Related]
53. Pravastatin and clopidogrel combined inhibit intimal hyperplasia in a rat carotid endarterectomy model.
Bledsoe SL; Barr JC; Fitzgerald RT; Brown AT; Faas FH; Eidt JF; Moursi MM
Vasc Endovascular Surg; 2006; 40(1):49-57. PubMed ID: 16456606
[TBL] [Abstract][Full Text] [Related]
54. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
55. Dietary supplementation with Zyflamend poly-herbal extracts and fish oil inhibits intimal hyperplasia development following vascular intervention.
Buckley MR; Terry PD; Kirkpatrick SS; Arnold JD; McNally MM; Grandas OH; Freeman MB; Goldman MH; Whelan J; Mountain DJ
Nutr Res; 2019 Aug; 68():34-44. PubMed ID: 31306903
[TBL] [Abstract][Full Text] [Related]
56. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
57. Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.
Hu A; Shuai Z; Liu J; Huang B; Luo Y; Deng J; Liu J; Yu L; Li L; Xu S
J Ethnopharmacol; 2020 Oct; 260():113046. PubMed ID: 32504784
[TBL] [Abstract][Full Text] [Related]
58. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
59. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
60. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression.
Hlawaty H; Suffee N; Sutton A; Oudar O; Haddad O; Ollivier V; Laguillier-Morizot C; Gattegno L; Letourneur D; Charnaux N
Biochem Pharmacol; 2011 Jan; 81(2):233-43. PubMed ID: 20887714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
